Boston Scientific Corporation (BSX) Options Active On Positive FDA Data

Boston Scientific Corporation (NYSE: BSX) shares have been in play as of late, fueled by take over and FDA chatter. Boston Scientific Corporation (NYSE: BSX) is in play this afternoon rising 5% on heavy volume (100mil vs 25mil avg). The move is being attributed to positive data coming out of the FDA stating, "Boston Scientific heart study met goals."

Options traders are actively buying at the money and out of the money calls. Currently the April 7 calls have traded 75% of the open interest by 2pm est. The 8 calls in further out months coupled with considerable open interest indicates there is considerable upside speculation in Boston Scientific (BSX).

52wk Range: 6.31 - 11.77